NICE has recommended Boehringer Ingelheim's novel anti-clotting pill Pradaxa, giving it a marketing edge over Bayer's rival treatment Xarelto. Pradaxa …
Bayer Schering says its new blood clotting drug Xarelto is poised to set a new standard of care for post-surgery …

